Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 1/20 | 0.48 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | REN | P00797 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP7 | P09237 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31151844 | 0.91 | REN (0.51) | CTSCCTSBRENOPRM1OPRD1 | |
| SCHEMBL30487449 | 0.90 | CTSC (0.57) | CTSCTERT | |
| SCHEMBL30052990 | 0.90 | CTSC (0.57) | CTSCTERT | |
| SCHEMBL30052854 | 0.86 | CTSC (0.56) | CTSCREN | |
| SCHEMBL29630612 | 0.86 | CTSC (0.53) | CTSCCTSBTERTRENOPRM1 | |
| SCHEMBL29630530 | 0.86 | CTSC (0.51) | CTSCTERTRENOPRM1OPRD1 | |
| SCHEMBL10364374 | 0.85 | CTSC (0.59) | CTSCACEREN | |
| SCHEMBL29630524 | 0.84 | REN (0.54) | CTSCREN | |
| SCHEMBL29906308 | 0.84 | MEN1 (0.43) | CTSCCTSBTERTREN | |
| SCHEMBL29570472 | 0.84 | TERT (0.51) | CTSCTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408802-B1 | CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME | GOVERNING COUNCIL UNIV TORONTO (CA) | 2017-05-03 | — | — | EP | disclosed |
| US-20120065366-A1 | CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065366-A1 | CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME | DNPEP, ANPEP, BCAT1 | CTSC 284/4885CTSB 2347/4885TERT 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.